|
Real-time Estimate
Cboe BZX
21:55:58 19/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 37.80 USD | +1.63% |
|
-1.55% | +52.55% |
| 10-16 | William Blar Initiates Coverage on Edgewise Therapeutics With Outperform Rating | MT |
| 10-08 | Edgewise Therapeutics Doses First Patient in Trial of Investigational Heart Failure Drug | MT |
| Market Cap | 4.04B 3.6B 3.34B 3.03B 5.69B 383B 5.78B 40B 15.73B 200B 15.15B 14.84B 640B | P/E 2026 * |
21.2x | P/E 2027 * | -18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.78B 2.48B 2.3B 2.09B 3.92B 264B 3.98B 27.53B 10.83B 138B 10.43B 10.21B 440B | EV / Sales 2026 * |
21.6x | EV / Sales 2027 * | 74.6x |
| Free-Float |
99.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| EWTX | Delayed | |
CBOE
| EWTX | Real-time |
Last Transcript: Edgewise Therapeutics, Inc.
| 1 day | +1.60% | ||
| 1 week | -1.82% | ||
| Current month | -7.02% | ||
| 1 month | -15.43% | ||
| 3 months | -2.73% | ||
| 6 months | +11.13% | ||
| Current year | +52.13% |
| 1 week | 35.63 |  | 38.53 |
| 1 month | 35.63 | | 45.99 |
| Current year | 22.78 | | 48.51 |
| 1 year | 14.68 | | 48.51 |
| 3 years | 5.12 | | 48.51 |
| 5 years | 5.12 | | 48.51 |
| 10 years | 5.12 | | 48.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alan Russell
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/06/2017 |
Kevin Koch
CEO | Chief Executive Officer | 65 | 01/08/2017 |
Michael Nofi
DFI | Director of Finance/CFO | 55 | 10/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Koch
BRD | Director/Board Member | 65 | 01/06/2017 |
Peter Thompson
CHM | Chairman | 67 | 01/08/2017 |
Alan Russell
BRD | Director/Board Member | 56 | 01/08/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Free | Director | 308 | 0.0003% | ||
| 13/08/26 | Sell | Chief Technology Officer | -2,919 | 0.0027% | ||
| 12/08/26 | Free | Chief Financial Officer | 48,750 | 0.0453% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.60% | -1.82% | +145.29% | +412.91% | 4.04B | |
| +1.52% | -7.16% | +51.66% | +67.41% | 65B | |
| +1.52% | +6.83% | +10.89% | +79.30% | 51.2B | |
| +0.30% | -0.46% | -0.03% | +61.89% | 51.19B | |
| -0.66% | +0.84% | +24.70% | +41.59% | 43.93B | |
| +0.61% | +5.69% | +16.24% | +133.40% | 41.96B | |
| +2.86% | -6.03% | +237.46% | +528.48% | 38.14B | |
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| +1.60% | +2.21% | +27.96% | +28.00% | 22.5B | |
| Average | +1.02% | -0.35% | +57.02% | +141.45% | 37.64B | |
| Weighted average by Cap. | +0.98% | -0.01% | +46.54% | +115.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 115M 106M 96.74M 182M 12.22B 185M 1.28B 502M 6.38B 483M 473M 20.41B | 39.17M 34.91M 32.34M 29.41M 55.18M 3.71B 56.09M 388M 153M 1.94B 147M 144M 6.2B |
| Net income | 210M 188M 174M 158M 296M 19.95B 301M 2.08B 819M 10.43B 789M 773M 33.33B | -220M -196M -181M -165M -309M -20.82B -314M -2.17B -855M -10.88B -824M -807M -34.78B |
| Net Debt | -1.26B -1.12B -1.04B -945M -1.77B -119B -1.8B -12.47B -4.9B -62.39B -4.72B -4.62B -199B | -1.12B -996M -923M -839M -1.57B -106B -1.6B -11.07B -4.35B -55.36B -4.19B -4.1B -177B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/10/26 | $37.86 | +1.79% | 661,601 |
| 16/10/26 | $37.19 | -2.64% | 1,305,481 |
| 15/10/26 | $38.20 | +3.19% | 1,837,467 |
| 14/10/26 | $37.02 | +2.04% | 1,446,128 |
| 13/10/26 | $36.28 | -5.64% | 810,154 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EWTX Stock
Select your edition
All financial news and data tailored to specific country editions
